IO Biotech
IOBT
IOBT
17 hedge funds and large institutions have $26.1M invested in IO Biotech in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.63M | |
| 2 | +$87.6K | |
| 3 | +$70.5K | |
| 4 |
Morgan Stanley
New York
|
+$26.5K |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$1.22M | |
| 3 | -$94K | |
| 4 |
NM
Newtyn Management
New York
|
-$76K |
| 5 |
Millennium Management
New York
|
-$1.18K |